- Comment
- Open access
- Published:
Transmission electron microscopy of transbronchial lung cryobiopsy samples in a cohort of fibrotic interstitial lung disease patients – feasibility and implications of endothelial alterations
Respiratory Research volume 25, Article number: 366 (2024)
Abstract
We evaluated the utility of transmission electron microscopy (TEM) in transbronchial lung cryobiopsy (TBLC) samples from 16 consecutive patients undergoing routine evaluation of fibrotic interstitial lung disease (ILD). Next to routine pathology examination, 1 to 2 TBLC samples were prepared for TEM analysis and evaluated using a Zeiss LEO EM 910. Subpleural cryobiopsies and unfrozen excision biopsies from fresh lobectomy tissue of non-ILD lung cancer patients served as controls. TEM provided high-quality images with only minor cryoartifacts as compared to controls. Furthermore, in several ILD patients we found marked microvascular endothelial abnormalities like luminal pseudopodia-like protrusions and inner surface defects. These were extensively present in four (25%), moderately present in seven (43.8%), and largely absent in five (31.3%) patients. A higher degree of TEM endothelial abnormalities was associated with younger age, non-specific interstitial pneumonia pattern, higher broncho-alveolar lavage lymphocyte count, positive autoantibodies, and lower spirometry, diffusion capacity and oxygenation biomarkers. We conclude that TEM evaluation of TBLC samples from ILD patients is feasible, while the observed microvascular alterations warrant further evaluation.
Brief report
The spectrum of fibrotic interstitial lung diseases (ILD) shares pathogenetic mechanisms of inflammation and fibrosis not only involving the interstitial space, but also the alveolar epithelium and the vascular endothelium [1, 2]. While light microscopy only allows for a limited perception of such processes [3, 4], transmission electron microscopy (TEM) enables deeper insights into cellular and subcellular structures, and can potentially visualize earlier disease-specific alterations [5]. Transbronchial lung cryobiopsy (TBLC) has proven a reasonable balance between quantity and quality of retrieved tissue and procedural risk, with a diagnostic yield similar to surgical lung biopsy [6]. As TBLC samples from fibrotic ILD patients have not been systematically studied by TEM so far, we assessed the feasibility of this approach and particularly microvascular alterations in a cohort of consecutive fibrotic ILD patients undergoing routine bronchoscopic evaluation at Kepler University Hospital Linz, Austria in the year 2023.
Patients with fibrotic ILD (i.e. with computed tomography evidence of a reticular pattern, traction bronchiectasis or honeycombing) provided written-informed consent to additional TEM evaluation 1 to 2 TBLC samples, given there was sufficient biopsy material for routine pathology examination. TBLC was performed according to current state-of-the-art [6], under general intravenous anaesthesia with rigid bronchoscopic intubation and jet ventilation. A balloon catheter for bleeding control was placed and a minimum of 4 TBLC samples were retrieved from two different lung segments under fluoroscopic control. Samples for TEM were fixed in a cacodylate-buffered solution of 2.5% glutaraldehyde and 2% paraformaldehyde, postfixed in 1% osmium tetroxide, and embedded in epoxy resin. Ultrathin sections were analyzed in a Zeiss LEO EM 910. Biopsy samples intended for routine light microscopy were fixed in 4% formalin and stained with Hematoxylin-Eosin (HE). For controls, subpleural fresh lobectomy tissue from lung cancer patients unaffected by ILD, participating in another study was sampled both by a cryoprobe inserted through a pleural incision, and by excision without freezing.
Of 18 patients enrolled, one sample for TEM analysis did not contain sufficient alveolar lung tissue, and in one patient, endobronchial bleeding kept the investigator from acquiring an additional sample for TEM. In the remaining 16 patients, TEM revealed good ultrastructural preservation and enabled the definition of a standardizable set of cryoartifacts as compared to three non-frozen controls: The cryosampled tissue was predominantly characterized by expanded interstitial spaces and a reduced electron density of cytoplasmic areas. This was commonly accompanied by an inflation of membranous compartments such as endoplasmatic reticula, and by mitochondrial swelling together with a loss of inner membrane structure and coherence. (Fig. 1a-c).
As compared to controls, the alveolar parenchyma of ILD lungs was characterized by larger deposits of collagen, elastic fibres, and presence of fibroblasts (Fig. 2c-f). In several cases, the basal membrane layers between capillary endothelia and pneumocytes were thickened, interspersed with collagen fibres and fibroblast protrusions (Figs. 1c and 2d).
The most evident TEM findings concerning microvascular morphology in a considerable fraction of patients were a marked transformation of capillary endothelia towards a thickened cell shape as compared to their normal squamous appearance, and the presence of numerous pseudopodia protruding into the lumina. Endothelial thickenings, either cushion-like or along the entire perimeter, together with the pseudopodia even lead to a complete capillary obstruction in extreme cases (Fig. 2c-f). These endothelial abnormalities were staged as grade 3 (highly present) in 4 patients (25%), as grade 2 (moderately present) in 7 patients (43.8%), and as grade 1 (largely absent) in 5 patients (31.3%). (Fig. 2)
Although less distinct than in TEM, routine light microscopy also revealed pathological vascular features in several patients, including swelling and increased number of endothelial cells and focal vessel proliferation. Analogously graded by severity, these were correlated with endothelial alterations detected in TEM (Table 1).
As shown in Table 1, patients with more advanced endothelial alterations were younger, more hypoxemic and had lower lung volumes and diffusion capacity. Radiologically, they more frequently exhibited a non-specific interstitial pneumonia (NSIP) pattern, had a higher lymphocyte count in broncho-alveolar lavage (BAL), and more frequently fulfilled the serological domain of interstitial pneumonia with autoimmune features. However, the grade 3 patients did not exhibit other classical signs of acute inflammation, neither locally such as lymphocyte aggregates and presence of lymph follicles in light microscopy, nor systemically such as elevations in relevant blood biomarkers like CRP and LDH (Table 1).
Our results demonstrate that diagnostic TEM examination of TBLC samples from ILD patients is feasible and enables high-quality ultrastructural imaging, with cryoartifacts occurring in a standardized fashion. Primarily, this implies that our described approach can be considered as a method for future research of fibrotic ILD, especially concerning microvascular processes. The number of patients in our study was low, so that no definite conclusions on the origin and significance of the vascular alterations detected can be drawn. Still, our findings of marked endothelial abnormalities in a subgroup of ILD patients once more emphasize the prominent role of the pulmonary endothelium in the pathophysiological processes underlying fibrotic ILD [2].
Although patients with stage 3 TEM endothelial alterations had a higher BAL lymphocyte count, presence of autoantibodies, and a radiological NSIP pattern in most cases, they exhibited rather less pronounced light microscopy signs of inflammation and inconspicuous levels of relevant systemic inflammation biomarkers. Such discrepancy between advanced endothelial transformation and the absence of fully developed local inflammation may indirectly correlate with the results of a post-mortem study on fatal COVID-19 pneumonia, where TEM failed to reveal significant endothelial abnormalities despite evidence of severe alveolar epithelial damage [7].
Of interest, similar luminal endothelial pseudopodia formation as seen in our cohort has been reported as a response to lack of capillary fluid flow in rat skeletal muscles [8], thus the observed capillary alterations could represent a response to altered blood flow conditions and shear stress in lung areas affected by ILD.
Research on systemic sclerosis and pulmonary arterial hypertension implies that microvascular remodelling could also be indicative of endothelial to mesenchymal transition [9, 10]. Alternatively, as the TEM stage 3 patients in the present study had lower spirometry, diffusion capacity and oxygenation biomarkers, the observed endothelial alterations could indicate hypoxemia-induced angiogenesis, however the entirely endoluminal fashion of the observed processes does not appear typical of new vessel formation [2].
The limitations of our reported analyses include the small sample size and the lack of the possibility of comparison with other, similar studies and with healthy individuals. The small control group was derived from cancer patients and the tissue from which the control biopsies were taken had been ischaemic for up to one hour before sampling, while cryobiopsies from ILD cases were processed immediately, within seconds after thawing. Also, given the advanced age of the patient population, it cannot be precluded that processes associated with normal ageing or with pulmonary comorbidities may have contributed to the observed endothelial alterations. Alveolar capillaries arise both from the systemic as well as from the pulmonary circulation and it cannot be clarified with certainty, whether the observed alterations are specific to either system. Also, not only the heterogeneity of ILD entities present in the studied cohort, but also the possible spatial heterogeneity of interstitial changes within a single patient’s lung could impair the comparison between cryobiopsy samples analyzed by TEM and those undergoing usual microscopic evaluation.
We suggest that TEM evaluation of TBLC samples from ILD patients is feasible, could enable novel insights into ILD pathophysiology, and should therefore be evaluated further in basic and clinical research. The observed microvascular alterations warrant evaluation in larger cohorts with a refined methodology.
Data availability
Anonymized data or imaging files can be shared on reasonable request to the authors if approved in an amendment to the study protocol by the ethics committee.
References
Heukels P, Moor CC, von der Thüsen JH, Wijsenbeek MS, Kool M. Inflammation and immunity in IPF pathogenesis and treatment. Respir Med [Internet]. 2019;147:79–91. https://linkinghub.elsevier.com/retrieve/pii/S0954611119300071
Fließer E, Lins T, Berg JL, Kolb M, Kwapiszewska G. The endothelium in lung fibrosis: a core signaling hub in disease pathogenesis? Am J Physiol Physiol [Internet]. 2023;325:C2–16. https://doi.org/10.1152/ajpcell.00097.2023
Yanagihara T, Jones KD. Demystifying morphomolecular alterations of vasculature in interstitial lung diseases. Eur Respir J [Internet]. 2020;55:1902446. http://erj.ersjournals.com/lookup/doi/https://doi.org/10.1183/13993003.02446-2019
Song JW, Do K-H, Kim M-Y, Jang SJ, Colby TV, Kim DS. Pathologic and Radiologic Differences Between Idiopathic and Collagen Vascular Disease-Related Usual Interstitial Pneumonia. Chest [Internet]. 2009;136:23–30. https://linkinghub.elsevier.com/retrieve/pii/S0012369209604025
Panchal A, Koss MN. Role of electron microscopy in interstitial lung disease. Curr Opin Pulm Med [Internet]. 1997;3:341–7. http://www.ncbi.nlm.nih.gov/pubmed/9331535
Maldonado F, Danoff SK, Wells AU, Colby TV, Ryu JH, Liberman M et al. Transbronchial Cryobiopsy for the Diagnosis of Interstitial Lung Diseases. Chest [Internet]. 2020;157:1030–42. https://linkinghub.elsevier.com/retrieve/pii/S0012369219342813
Cortese K, Holland G, Möller L, Gagliani MC, Barisione E, Ball L et al. Ultrastructural examination of lung cryobiopsies from a series of fatal COVID-19 cases hardly revealed infected cells. Virchows Arch [Internet]. 2022;480:967–77. https://link.springer.com/https://doi.org/10.1007/s00428-022-03308-5
Hueck IS, Rossiter K, Artmann GM, Schmid-Schönbein GW. Fluid Shear Attenuates Endothelial Pseudopodia Formation into the Capillary Lumen. Microcirculation [Internet]. 2008;15:531–42. https://onlinelibrary.wiley.com/doi/10.1080/10739680801904174
Jimenez SA, Piera-Velazquez S. Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality? Matrix Biol [Internet]. 2016;51:26–36. https://linkinghub.elsevier.com/retrieve/pii/S0945053X16000056
Ranchoux B, Antigny F, Rucker-Martin C, Hautefort A, Péchoux C, Bogaard HJ et al. Endothelial-to-Mesenchymal Transition in Pulmonary Hypertension. Circulation [Internet]. 2015;131:1006–18. https://www.ahajournals.org/doi/https://doi.org/10.1161/CIRCULATIONAHA.114.008750
Acknowledgements
Supported by the Johannes Kepler Open Access Publishing Fund and the federal state of Upper Austria.
Funding
This research did not receive any external funding.
Author information
Authors and Affiliations
Contributions
Conceptualization: DL, WS, AO, SLS. Methodology: DL, WS, AO, SLS, RL, BL, BK . Software: DL, SLS, AO, BK. Validation: DL, BK. Formal analysis: DL, BK. Investigation: DL, WS, AO, SLS, GS . Resources: DL, WS, AO, SLS, GS. Data Curation: DL, WS, AO, SLS. Writing - Original Draft: DL, WS, AO, SLSWriting - Review & Editing: DL, WS, AO, SLS, GS, BK, RL, BL. Visualization: DL, WS, AO, SLS. Supervision: DL, WS, RL, BL. Project administration: DL, WS, SLS, RL, BL. Funding acquisition: n.a.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
This study was conducted in accordance with the Declaration of Helsinki. The study protocol and all study-related procedures including handling and analysis of patient data have been reviewed and approved by the ethics committee of the medical faculty of Johannes Kepler University Linz (EK Nr. 1287/2022). All patients provided written-informed consent to participate in the study according to the protocol.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Lang, D., Stoiber, W., Lohfink-Schumm, S. et al. Transmission electron microscopy of transbronchial lung cryobiopsy samples in a cohort of fibrotic interstitial lung disease patients – feasibility and implications of endothelial alterations. Respir Res 25, 366 (2024). https://doi.org/10.1186/s12931-024-02981-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12931-024-02981-1